Mutual Fund Series Trust · net assets $46.6M · 62 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 95.7% · STIV: 4.3%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $196K | $439K | $1.18M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $275K | $319K | $920K |
| Net realized gain (non-derivative) | $0 | $146K | $314K |
| Net unrealized appreciation (non-derivative) | $153K | $1.64M | $4.84M |
The three months of the reporting period, as filed; month 3 ends June 30, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Gilead Sciences Inc EC | $2.58M | 5.53% |
| Vertex Pharmaceuticals Inc EC | $2.48M | 5.33% |
| Astrazeneca PLC EC | $2.16M | 4.63% |
| First American Funds Inc STIV | $1.99M | 4.26% |
| Roivant Sciences Ltd EC | $1.71M | 3.67% |
| Argenx Se EC | $1.68M | 3.59% |
| Neurocrine Biosciences Inc EC | $1.64M | 3.51% |
| Incyte Corp EC | $1.64M | 3.51% |
| Axsome Therapeutics Inc EC | $1.6M | 3.43% |
| Apogee Therapeutics Inc EC | $1.53M | 3.28% |
| Ionis Pharmaceuticals Inc EC | $1.22M | 2.62% |
| Ascendis Pharma A/s EC | $1.22M | 2.62% |
| Insmed Inc EC | $1.21M | 2.60% |
| Protagonist Therapeutics Inc EC | $1.12M | 2.41% |
| Personalis Inc EC | $1.06M | 2.27% |
| Rhythm Pharmaceuticals Inc EC | $1.05M | 2.25% |
| Abbvie Inc EC | $909K | 1.95% |
| Jazz Pharmaceuticals PLC EC | $871K | 1.87% |
| Amgen Inc EC | $855K | 1.83% |
| Biogen Inc EC | $841K | 1.80% |
| Catalyst Pharmaceuticals Inc EC | $742K | 1.59% |
| Halozyme Therapeutics Inc EC | $738K | 1.58% |
| Meiragtx Holdings PLC EC | $736K | 1.58% |
| Krystal Biotech Inc EC | $723K | 1.55% |
| Nuvalent Inc EC | $686K | 1.47% |
| Abivax Sa EC | $685K | 1.47% |
| Edgewise Therapeutics Inc EC | $644K | 1.38% |
| Nurix Therapeutics Inc EC | $627K | 1.34% |
| Sanofi Sa EC | $622K | 1.33% |
| Oruka Therapeutics Inc EC | $622K | 1.33% |
| Kymera Therapeutics Inc EC | $617K | 1.32% |
| Spyre Therapeutics Inc EC | $592K | 1.27% |
| Biontech Se EC | $583K | 1.25% |
| Agios Pharmaceuticals Inc EC | $526K | 1.13% |
| Newamsterdam Pharma Company Nv EC | $504K | 1.08% |
| Cytokinetics Inc EC | $485K | 1.04% |
| Celldex Therapeutics Inc EC | $476K | 1.02% |
| Trevi Therapeutics Inc EC | $454K | 0.97% |
| Alnylam Pharmaceuticals Inc EC | $418K | 0.90% |
| Veracyte Inc EC | $408K | 0.87% |
| Candel Therapeutics Inc EC | $378K | 0.81% |
| Natera Inc EC | $377K | 0.81% |
| Rezolute Inc EC | $376K | 0.81% |
| Cullinan Therapeutics Inc EC | $372K | 0.80% |
| Crinetics Pharmaceuticals Inc EC | $369K | 0.79% |
| Xeris Biopharma Holdings Inc EC | $369K | 0.79% |
| Design Therapeutics Inc EC | $312K | 0.67% |
| Monte Rosa Therapeutics Inc EC | $306K | 0.66% |
| Disc Medicine Inc EC | $295K | 0.63% |
| Rapport Therapeutics Inc EC | $272K | 0.58% |
| Arvinas Inc EC | $254K | 0.55% |
| Icon PLC EC | $241K | 0.52% |
| Tectonic Therapeutic Inc EC | $239K | 0.51% |
| Sionna Therapeutics Inc EC | $214K | 0.46% |
| Wave Life Sciences Ltd EC | $207K | 0.44% |
| Intellia Therapeutics Inc EC | $197K | 0.42% |
| Atrium Therapeutics Inc EC | $181K | 0.39% |
| Iqvia Holdings Inc EC | $161K | 0.35% |
| Annexon Inc EC | $142K | 0.30% |
| Adma Biologics Inc EC | $84.9K | 0.18% |
Showing top 60 of 62 holdings.
Loading...
